Share Search
Visit the Share Search
Astrazeneca Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | 58,739.00 | 54,073.00 | 45,811.00 | 44,351.00 | 37,417.00 |
| Operating Profit / Loss | 13,743.00 | 10,003.00 | 8,193.00 | 3,757.00 | 1,056.00 |
| Net Interest | -1,334.00 | -1,284.00 | -1,282.00 | -1,251.00 | -1,257.00 |
| Pre Tax Profit | 12,402.00 | 8,691.00 | 6,899.00 | 2,501.00 | -265.00 |
| Post Tax Profit | 10,233.00 | 7,041.00 | 5,961.00 | 3,293.00 | 115.00 |
| Profit for the Period | 10,233.00 | 7,041.00 | 5,961.00 | 3,293.00 | 115.00 |
| Equity Holders of Parent Company | 10,225.00 | 7,035.00 | 5,955.00 | 3,288.00 | 112.00 |
| Minority Interests | 8.00 | 6.00 | 6.00 | 5.00 | 3.00 |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 660.00 USX | 454.00 USX | 384.00 USX | 212.00 USX | 8.00 USX |
| Earnings per Share (Diluted) | 654.00 USX | 450.00 USX | 381.00 USX | 211.00 USX | 8.00 USX |
| Earnings per Share (Adjusted) | 660.00 USX | 454.00 USX | 726.00 USX | 212.00 USX | 8.00 USX |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 660.00 USX | 454.00 USX | 384.00 USX | 212.00 USX | 8.00 USX |
| Earnings per Share (Diluted) | 654.00 USX | 450.00 USX | 381.00 USX | 211.00 USX | 8.00 USX |
| Earnings per Share (Adjusted) | 660.00 USX | 454.00 USX | 726.00 USX | 212.00 USX | 8.00 USX |
| Dividend per Share | 3.20 USD | 3.10 USD | 2.90 USD | 2.90 USD | 2.87 USD |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | 59,088.00 | 58,202.00 | 58,137.00 | 59,127.00 | 62,384.00 |
| Property, Plant and Equipment | 14,703.00 | 11,647.00 | 10,502.00 | 9,449.00 | 10,171.00 |
| Investments | 2,525.00 | 1,900.00 | 1,677.00 | 1,142.00 | 1,237.00 |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | 228.00 | n/a | n/a |
| Other Non-Current Assets | 9,035.00 | 6,459.00 | 5,521.00 | 4,172.00 | 5,327.00 |
| Total Non-Current Assets | 85,351.00 | 78,208.00 | 76,065.00 | 73,890.00 | 79,119.00 |
| Current Assets | |||||
| Inventories | 6,557.00 | 5,288.00 | 5,424.00 | 4,699.00 | 8,983.00 |
| Trade and Other Receivables | 15,177.00 | 12,972.00 | 12,126.00 | 11,252.00 | 10,307.00 |
| Cash at Bank and in Hand | 5,711.00 | 5,488.00 | 5,840.00 | 6,166.00 | 6,329.00 |
| Current Asset Investments | n/a | n/a | n/a | 239.00 | 69.00 |
| Other Current Assets | 1,278.00 | 2,079.00 | 1,664.00 | 87.00 | 556.00 |
| Total Current Assets | 28,723.00 | 25,827.00 | 25,054.00 | 22,443.00 | 26,244.00 |
| Other Assets | n/a | n/a | n/a | 150.00 | n/a |
| Total Assets | 114,074.00 | 104,035.00 | 101,119.00 | 96,483.00 | 105,363.00 |
| Current Liabilities | |||||
| Borrowings | 3,486.00 | 2,676.00 | 5,400.00 | 5,542.00 | 1,893.00 |
| Other Current Liabilities | 27,131.00 | 25,190.00 | 25,142.00 | 20,751.00 | 20,701.00 |
| Total Current Liabilities | 30,617.00 | 27,866.00 | 30,542.00 | 26,293.00 | 22,594.00 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 26,136.00 | 27,619.00 | 23,222.00 | 23,690.00 | 28,888.00 |
| Provisions | 4,418.00 | 4,226.00 | 2,844.00 | 3,840.00 | 7,162.00 |
| Other Non-Current Liabilities | 4,184.00 | 3,453.00 | 5,345.00 | 5,602.00 | 7,432.00 |
| Total Non-Current Liabilities | 34,738.00 | 35,298.00 | 31,411.00 | 33,132.00 | 43,482.00 |
| Net Assets | 48,719.00 | 40,871.00 | 39,166.00 | 37,058.00 | 39,287.00 |
| Capital and Reserves | |||||
| Share Capital | 388.00 | 388.00 | 388.00 | 387.00 | 387.00 |
| Share Premium Account | 35,266.00 | 35,226.00 | 35,188.00 | 35,155.00 | 35,126.00 |
| Other Reserves | 2,041.00 | 2,012.00 | 2,065.00 | 2,069.00 | 2,045.00 |
| Retained Earnings | 10,972.00 | 3,160.00 | 1,502.00 | -574.00 | 1,710.00 |
| Shareholders Funds | 48,667.00 | 40,786.00 | 39,143.00 | 37,037.00 | 39,268.00 |
| Minority Interests / Other Equity | 52.00 | 85.00 | 23.00 | 21.00 | 19.00 |
| Total Equity | 48,719.00 | 40,871.00 | 39,166.00 | 37,058.00 | 39,287.00 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | 23.40% | 18.50% | 17.88% | 8.47% | 2.82% |
| Return on Capital Employed | 58.03% | 58.03% | 65.47% | 34.10% | 6.68% |
| Dividend Cover | 2.06 | 1.46 | 2.50 | 0.73 | 0.03 |
| Dividend Yield | 1.70 | 2.20 | 2.00 | 1.90 | 2.40 |
| PE Ratio | 28.50 | 31.40 | 19.90 | 72.10 | 1,477.80 |
| PEG | 0.60 | n/a | 0.10 | n/a | n/a |
| Dividend per Share Growth | 3.23% | 6.90% | n/a% | 1.05% | 2.50% |
| Net Asset Value per Share | -6.69 USD | -11.17 USD | -12.23 USD | -14.23 USD | -14.89 USD |